Blueprint Medicines Provides 2025 Outlook and Highlights Strategy for Continued Growth
Blueprint Medicines Corporation (Nasdaq: BPMC) today provided a 2025 corporate outlook and strategy for continued growth ...
Le Lézard10h
Lexmark Showcases New Printers and Technology Solutions for Retailers at NRF 2025
Lexmark, a global imaging and IoT solutions leader, will showcase its cutting-edge, retail-ready printers and solutions at NRF 2025, Retail's Big Show and Expo, Jan. 12 to 14, at the Jacob K. Javits ...
Curevo Announces Positive Updated Phase 2 Data for Amezosvatein Shingles Vaccine
One year after the second vaccine dose, the anti-gE antibody immune response to amezosvatein continues to be non-inferior to ShingrixSEATTLE, ...
Mereo BioPharma Provides Update on Lead Clinical Programs
Orbit Phase 3 study of setrusumab in osteogenesis imperfecta continuing to planned second interim analysis, expected in mid-2025Alvelestat, for ...
BlackDoctor6h
10 Steps for a Successful Cancer Clinical Trial
If you or a loved one is considering participating in a cancer clinical trial, this 10-step guide will help you navigate the ...